Credit Suisse’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-220,751
Closed -$694K 4574
2020
Q3
$694K Sell
220,751
-24,562
-10% -$78.5K ﹤0.01% 3190
2020
Q2
$714K Buy
245,313
+183,654
+298% +$581K ﹤0.01% 3113
2020
Q1
$174K Sell
61,659
-40,078
-39% -$129K ﹤0.01% 3695
2019
Q4
$330K Buy
101,737
+16,091
+19% +$46.7K ﹤0.01% 3781
2019
Q3
$185K Sell
85,646
-20,635
-19% -$55.2K ﹤0.01% 3879
2019
Q2
$333K Buy
106,281
+10,609
+11% +$34.4K ﹤0.01% 3637
2019
Q1
$356K Sell
95,672
-47,382
-33% -$160K ﹤0.01% 3526
2018
Q4
$414K Sell
143,054
-897
-0.6% -$2.46K ﹤0.01% 3354
2018
Q3
$379K Sell
143,951
-112,249
-44% -$275K ﹤0.01% 3436
2018
Q2
$600K Buy
256,200
+5,342
+2% +$14.9K ﹤0.01% 3332
2018
Q1
$738K Sell
250,858
-64,205
-20% -$175K ﹤0.01% 3157
2017
Q4
$864K Sell
315,063
-44,331
-12% -$136K ﹤0.01% 3103
2017
Q3
$1.22M Buy
359,394
+149,995
+72% +$417K ﹤0.01% 2943
2017
Q2
$518K Sell
209,399
-21,602
-9% -$49.7K ﹤0.01% 3140
2017
Q1
$525K Sell
231,001
-39,644
-15% -$87.7K ﹤0.01% 3245
2016
Q4
$573K Buy
270,645
+1,350
+0.5% +$3.77K ﹤0.01% 3371
2016
Q3
$902K Sell
269,295
-64,296
-19% -$204K ﹤0.01% 3044
2016
Q2
$1.05M Buy
333,591
+67,561
+25% +$225K ﹤0.01% 2879
2016
Q1
$886K Buy
266,030
+14,643
+6% +$45.6K ﹤0.01% 2819
2015
Q4
$889K Buy
251,387
+96,361
+62% +$403K ﹤0.01% 2914
2015
Q3
$779K Sell
155,026
-222,972
-59% -$1.28M ﹤0.01% 3057
2015
Q2
$2.43M Buy
377,998
+109,998
+41% +$737K ﹤0.01% 2393
2015
Q1
$1.89M Sell
268,000
-1,481
-0.5% -$10.7K ﹤0.01% 2441
2014
Q4
$2.08M Sell
269,481
-30,714
-10% -$243K ﹤0.01% 2502
2014
Q3
$2.24M Sell
300,195
-1,872
-0.6% -$17.4K ﹤0.01% 2402
2014
Q2
$2.92M Buy
302,067
+45,812
+18% +$408K ﹤0.01% 2399
2014
Q1
$2.13M Sell
256,255
-316,719
-55% -$2.71M ﹤0.01% 2466
2013
Q4
$4.84M Buy
572,974
+85,225
+17% +$718K ﹤0.01% 1874
2013
Q3
$3.89M Sell
487,749
-74,229
-13% -$597K ﹤0.01% 1845
2013
Q2
$4.34M Buy
+561,978
New +$4.38M ﹤0.01% 1689

Other funds holding PDLI